FDA warning: Co-administration of statins and protease inhibitors increases risk of muscle injury

Allergy & ImmunologyCardiovascular DiseaseClinical PharmacologyCosmetic SurgeryDermatologyEndocrinologyGastroenterologyGeriatricsInfectious DiseaseInternal MedicineLocum Tenens Managed Care & Medicare Part DMedical EconomicsNeurologyNursingNutritionObstetrics/Gynecology & Women's HealthOncologyOphthalmologyOrthopedicsPathology PediatricsPharmacyPrimary Care MedicinePsychiatry & Behavioral HealthRadiologySurgerySurgical Video CenterUrology

View the original article here